2026-04-25T13:12:20Z https://www.pub.unibl.org/oai

oai:pub.unibl.org:66290 2026-01-20T04:43:23Z

How would you treat: glucagon-like peptide 1 receptor analogue or sodium-glucosecotransporter 2 inhibitor in chronic coronary syndrome and heart failure in type 2diabetes? /unibl/author/Tamara Kovačević Preradović /unibl/author/Željo Živanović /unibl/author/Bojan Stanetić /unibl/author/Ljilja Kos https://www.unibl.org/sr-lat/fis/zaposlen/7059-nikola-sobot /unibl/author/Sanja Stojaković /unibl/author/Dragan Unčanin 2020-02 Academic Article text 10 8 /unibl/sci/idNaucniRad:37004 Srce i krvni sudovi 1821-4835 Srce i krvni sudovi 1821-4835 Kovacevic Preradovic T, Zivanovic Z, Stanetic B, Kos L, Sobot N, Stojakovic S, Uncanin D, How would you treat: glucagon-like peptide 1 receptor analogue or sodium-glucosecotransporter 2 inhibitor in chronic coronary syndrome and heart failure in type 2diabetes?, Srce i krvni sudovi, Vol. 39, No. 1, pp. 8 - 10, Feb, 2020 https://www.pub.unibl.org/s/cir/item/66290